Vertex said it made $2 million in revenue from the first patient who received its sickle cell therapy Casgevy.
The commercial launches of Casgevy and …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
SAN DIEGO — Investigational once-weekly insulin icodec outperformed once-daily insulin glargine U100 when it came to glycemic control in type 2 diabetes, the phase IIIa
DENVER — Genetic testing and algorithms revealed that over 1% of more than 96,000 blastocyst-stage embryos had ploidy abnormalities, or atypical numbers of chromosomes. In
Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Siemens Healthineers has agreed to